Chronotherapeutic lifestyle intervention for diabetes and obesity
Evidence has accumulated that disruption of our body’s internal clock (the so-called circadian clock) might contribute to the development of Type 2 diabetes and other cardiometabolic complications.
Few studies have investigated the link between the disruption of the daily sleep-wake pattern and Type 2 diabetes in man. For this reason, a multi-disciplinary consortium of leading academic experts and research-intensive SME’s joined forces under EuRhythDia, the Consortium on chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population.
The project looked at whether lifestyle change to resent the internal clock can significantly reduce the risk of developing type 2 diabetes and cardiometabolic complications.
